HK Stock Market Move | LUYUAN GP HLDG (02451) surged over 7% in morning trading; embodied intelligence is expected to become an important new growth driver in the company's "one body, two wings" strategy.
LUYUAN GP HLDG (02451) surged over 7% in morning trading. As of press time, it rose 5.65% to HK$13.64, with a turnover of HK$11.9874 million.
LUYUAN GP HLDG (02451) rose over 7% in morning trading. As of press time, it was up 5.65% at HK$13.64, with a turnover of HK$11.9874 million.
On the news front, LUYUAN GP HLDG recently disclosed its interim results and held a communication meeting, detailing the latest progress of its "one body, two wings" strategy. Against the backdrop of the industry entering a stock replacement cycle and competition in electric two-wheelers shifting from scale expansion to quality upgrading, the company takes its domestic two-wheeler and three-wheeler businesses as its base, with overseas operations and embodied intelligence as the two new growth wings.
Zheshang issued a research report stating that Luyuan is advancing orders for over 100,000 sets of high-precision planetary reduction joint modules and 10,000 complete units, with the business gradually moving from early-stage technology and product validation into large-scale manufacturing and commercialization. Affected by product upgrades, the delivery pace has been pushed back, with approximately 50% of manufacturing deliveries expected to be completed in 2026 and the remainder in 2027H1. As core components and complete unit orders are progressively fulfilled, embodied intelligence is expected to become an important new increment in the company's "one body, two wings" strategy.
Related Articles

HK Stock Market Move | CARSGEN-B (02171) rose nearly 3% in the morning as the FNC lymphodepletion preconditioning regimen received formal patent authorization in China.

Hunan Junxin Environmental Protection (301109.SZ) published its post-hearing information pack for the H-share issuance.

HK Stock Market Move | GENSCRIPT BIO (01548) rose more than 5% in morning trading; JP Morgan believes the market remains highly interested in GenScript's AIDD business.
HK Stock Market Move | CARSGEN-B (02171) rose nearly 3% in the morning as the FNC lymphodepletion preconditioning regimen received formal patent authorization in China.

Hunan Junxin Environmental Protection (301109.SZ) published its post-hearing information pack for the H-share issuance.

HK Stock Market Move | GENSCRIPT BIO (01548) rose more than 5% in morning trading; JP Morgan believes the market remains highly interested in GenScript's AIDD business.

RECOMMEND





